scholarly journals Human Adipose Stromal Cells (ASC) for the Regeneration of Injured Cartilage Display Genetic Stability after In Vitro Culture Expansion

PLoS ONE ◽  
2013 ◽  
Vol 8 (10) ◽  
pp. e77895 ◽  
Author(s):  
Simona Neri ◽  
Philippe Bourin ◽  
Julie-Anne Peyrafitte ◽  
Luca Cattini ◽  
Andrea Facchini ◽  
...  
2004 ◽  
Vol 181 (3) ◽  
pp. 477-492 ◽  
Author(s):  
AA Fouladi Nashta ◽  
CV Andreu ◽  
N Nijjar ◽  
JK Heath ◽  
SJ Kimber

Decidualisation of uterine stromal cells is a prerequisite for implantation of the embryo in mice. Here we have used an in vitro culture system in which stromal cells decidualise as indicated by a number of markers, including an increase in alkaline phosphatase (ALP) activity. The latter was used as a quantitative marker of decidualisation in the presence of low (2%) fetal calf serum. Prostaglandin E(2) (PGE(2)), which is known to induce decidualisation, increased ALP activity, and this effect was blocked in a dose-dependent manner by indomethacin. Leukemia inhibitory factor (LIF) was then examined, but it had no effect on PGE(2) secretion. However, LIF suppressed ALP activity in a dose-dependent manner in the presence of 2% serum, while an inhibitor of LIF that competes for binding to its receptor reversed the effect of LIF and increased ALP activity above the control level. In serum-free cultures, stromal cells differentiated rapidly, and no differences were observed between LIF-treated and untreated cultures. Stromal cells produce LIF during in vitro culture, and this peaked at 48 h. Freshly collected stromal cells from both day-2 and -4 pregnant mice expressed mRNA for the LIF receptor, and the transcript level was higher in cells isolated on day 4. However, no differences were observed in the relative levels of transcripts in cells from day 2 and day 4 after culture, nor were there differences between the LIF-treated cultures and controls. Therefore, in this study, we have shown that LIF suppresses decidualisation of murine uterine stromal cells in the presence of serum, this is not due to the regulation of PGE(2) secretion by stromal cells.


Author(s):  
Abbas Ali Qayyum ◽  
Kamal Preet Kaur ◽  
Anders Bruun Mathiasen ◽  
Mandana Haack-Sørensen ◽  
Annette Ekblond ◽  
...  

PLoS ONE ◽  
2016 ◽  
Vol 11 (12) ◽  
pp. e0167555 ◽  
Author(s):  
Yotam E. Bar-Ephraim ◽  
Tanja Konijn ◽  
Mehmet Gönültas ◽  
Reina E. Mebius ◽  
Rogier M. Reijmers

2005 ◽  
Vol 328 (1) ◽  
pp. 258-264 ◽  
Author(s):  
Min Jeong Seo ◽  
Su Young Suh ◽  
Yong Chan Bae ◽  
Jin Sup Jung

2015 ◽  
Vol 21 (11-12) ◽  
pp. 1952-1962 ◽  
Author(s):  
Beth A. Lindborg ◽  
John H. Brekke ◽  
Carolyn M. Scott ◽  
Yi Wen Chai ◽  
Connor Ulrich ◽  
...  

Blood ◽  
2006 ◽  
Vol 108 (11) ◽  
pp. 5020-5020 ◽  
Author(s):  
Saeid Abroun ◽  
Ken-Ichiro Otsuyama ◽  
Karim Shamsasenjan ◽  
Khademul Islam ◽  
Jaki Amin ◽  
...  

Abstract In order to clarify the pathogenesis of multiple myeloma (MM) and identify the molecular target for MM treatment, it is important to understand the biology and molecular mechanism of survival and proliferation of myeloma cells in vitro and in vivo. Still, it is hard to keep primary myeloma cells viable at least for 2 weeks in vitro, and these cells rapidly enter apoptosis even in the presence of IL-6. Co-culture with BM stromal cells is considered to be one of the most important factors as well as addition of cytokines for improvement of in vitro culture of primary myeloma cells. Based on our previous data, we devised a new method where bone marrow mononuclear cells (BMMNC) from BM aspirates were put inside insert-wells (8.0 um pore size, #3182, BD) coated with gelatin in the presence of the mixture of cytokines (galectin-1, SDF-1, IL-6 and IGF-1) in the serum-free synthetic medium; addition of galectin-1 and SDF-1 was essential especially at the beginning of this culture. By this method, we observed that BM stromal cells attached to gelatin and survived well with rather low proliferation; myeloma cells interacted well with these stromal cells. Thus, we could maintain viability of primary myeloma cells at least for 4 weeks and the recovery of viable myeloma cells (CD38++ cell) appeared to be about 80% in 30 cases of MM we examined. Phenotypic data also showed that ratio of immature (MPC-1−) and mature (MPC-1+) myeloma cells in the BMMNC before culture was approximately maintained after 2 or 4 weeks in this method. Therefore, these results suggest that gelatin-coated insert-well culture can control the viability of stromal cells and thus maintain the culture of primary myeloma cells in vitro. This new method would contribute to the further understanding of biology and drug sensitivity of primary myeloma cells.


Sign in / Sign up

Export Citation Format

Share Document